Article Text

PDF
Pharmacoeconomic considerations regarding hospice and palliative care according to pharmacists and hospice managers
  1. Iga Pawłowska1,
  2. Leszek Pawłowski2,
  3. Monika Lichodziejewska-Niemierko2,
  4. Ivan Kocić1
  1. 1Department of Pharmacology, Medical University of Gdańsk, Gdańsk, Poland
  2. 2Department of Palliative Medicine, Medical University of Gdańsk, Gdańsk, Poland
  1. Correspondence to Dr Iga Pawłowska, Department of Pharmacology, Medical University of Gdańsk, Dębowa Str. 23, Gdańsk 80-204, Poland; iga112{at}gumed.edu.pl

Abstract

This study focused on pharmacoeconomic issues affecting pharmacists in residential hospices in Poland. We conducted a questionnaire survey among hospice pharmacists and their managers. The results revealed that the amount of money received from the National Health Fund is insufficient for drug purchasing and therefore hospices often raise additional funds from external sources. Because of the limited financing, pharmacists and hospice directors undertake various activities to reduce costs. Generic drug reimbursement, pharmacoeconomic analysis and participating in tenders to purchase drugs are the most common measures undertaken to decrease expenditure.

  • CLINICAL PHARMACY
  • PALLIATIVE CARE
  • DRUG PROCUREMENT
  • HEALTH ECONOMICS
  • PHARMACY MANAGEMENT (ORGANISATION, FINANCIAL)

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.